Page 636 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 636

44









                                                           Atopic and Contact Dermatitis



                                                             Mark Boguniewicz, Luz Fonacier, Donald Y.M. Leung







           Atopic dermatitis (AD) and contact dermatitis (CD) are common   age, other diseases need to be considered in adults with new-onset
                                 1,2
           inflammatory skin diseases.  The complex pathophysiology of   dermatitis, especially in those without a history of childhood
           AD involves both underlying skin barrier abnormalities and   eczema, asthma, or allergic rhinitis (see Table 44.1, Differential
           immune dysregulation. Its course is augmented by environmental   Diagnosis).  Although in some children,  AD may progress to
           influences, including stress, allergen exposure, and microbial   milder forms of eczema, only in approximately one-third will
           infection. Patients with AD experiencing a relapsing course benefit   the disease be eliminated altogether. Severity and atopic sensitiza-
           from a proactive approach with skin emollients and antiinflam-  tion are major determinants of prognosis. A US registry of patients
           matory therapy (e.g., intermittent use of a topical steroid or   with mild-moderate AD showed that it was not until age 20
           calcineurin inhibitor). The identification of new immune pathways   years that 50% had experienced at least one 6-month period
           associated with AD has resulted in the development of novel   free of symptoms and treatments. 5
           biologicals targeting patients with refractory AD.
             CD is a skin disorder caused by contact with an exogenous   Clinical Features
           substance that elicits an allergic and/or irritant response. Allergic   AD has no pathognomonic skin lesions or unique laboratory
           contact dermatitis (ACD) accounts for 20%, whereas irritant   parameters; the diagnosis is, therefore, based on the presence of
           contact dermatitis (ICD) accounts for 80% of all cases of CD.   major and associated clinical features (Table 44.2). The principal
           ACD is a delayed-type, T cell–mediated immune response   features include pruritus, a chronically relapsing course, typical
           consisting of an afferent limb and an efferent limb. Irritants   morphology and distribution of skin lesions, and a history of
           cause direct activation of the innate immune system through   atopic disease. Patients usually have dry xerotic skin, and those
           hyperproduction of cytokines and chemokines. The management   with mutations of the gene encoding the epidermal barrier protein
           of  ACD includes identification of the allergen, avoidance,   filaggrin (FLG) typically have prominent scaling and hyperlinear
           pharmacological  intervention,  and  prevention.  This  chapter   palms. Acute AD is characterized by pruritic, erythematous papules
           reviews the clinical and mechanistic aspects of both AD and CD.  associated with excoriations, vesiculations, and serous exudate.
                                                                  Subacute AD is characterized by erythematous, excoriated, scaling
           CLINICAL ASPECTS OF ATOPIC DERMATITIS                  papules, whereas chronic AD is characterized by lichenification
                                                                  and fibrotic papules. During infancy, AD involves primarily the
           Epidemiology                                           face, scalp, and the extensor aspects of the extremities; the diaper
           Prevalence of AD has been documented in up to 24% of children,   region is typically spared, although some infants manifest the
           with no apparent difference seen between urban and rural districts   flexural involvement typical of older patients (Fig. 44.1).
           or between the two sexes. Children from families with atopy
           have a significantly higher risk of developing AD. Data from an   Complicating Features
           international study (ISAAC Phase 3) showed that prevalence of   Ocular Problems
           current eczema in children varies widely among countries, ranging   Atopic keratoconjunctivitis is  bilateral,  with  intense pruritus,
           from 0.9% to 22.5%, and in adolescents, the prevalence ranges   burning, tearing, and copious mucoid discharge. It is frequently
                            3
           from 0.2% to 24.6%.  These data point to the significance of   associated with eyelid dermatitis and chronic blepharitis and
           AD being a global health problem in both developed and develop-  may result in visual impairment from corneal scarring. Patients
           ing countries and suggest that the ultimate presentation of an   may also develop keratoconus from persistent rubbing of the
           atopic disease may depend on a complex interaction between   eyes or anterior subcapsular cataracts.
           environmental exposures and end-organ response in genetically
           predisposed individuals. Prevalence of adult eczema from a   Hand Dermatitis
           nationally representative sample found that the 1-year prevalence   Patients with AD may have a nonspecific irritant hand dermatitis
           of eczema was 10.2% and that the 1-year prevalence of eczema   aggravated by repeated wetting, especially in an occupational
           with asthma and/or hay fever was 3.2%. 4               setting.
           Natural History                                        Infections
           AD typically manifests in early childhood, with onset in the first   Patients with AD have an increased susceptibility to infection
                                                                                                   2
           year occurring in >50% of patients and before 5 years of age in   or colonization with a variety of organisms.  Staphylococcus aureus
           approximately 90% of patients. Although AD can present at any   can be cultured from the skin of the majority of patients with
                                                                                                                611
   631   632   633   634   635   636   637   638   639   640   641